ConductScience.org, home

Paper42450296

Who Reduces Silver? A Critical Review of the Biomolecular Drivers of Fungal-Mediated Silver Nanoparticle Biosynthesis.

Vorkapić M and 3 others. Int J Mol Sci, 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Who Reduces Silver? A Critical Review of the Biomolecular Drivers of Fungal-Mediated Silver Nanoparticle Biosynthesis. Papers, record 42450296. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42450296

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Who Reduces Silver? A Critical Review of the Biomolecular Drivers of Fungal-Mediated Silver Nanoparticle Biosynthesis.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-08-13
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Vorkapić MMislavhttps://orcid.org/0009-0009-9471-1308
2Filipović NNikolinahttps://orcid.org/0000-0003-3127-3442
3Stanković AAnamarijahttps://orcid.org/0000-0001-5090-0435
4Amić AAna

Source PubMed

Download CSV of authors

Topics3

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Metal NanoparticlesMajor topic
SilverMajor topic
FungiMajor topic

References82

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135740206Optimized Synthesis of Small and Stable Silver Nanoparticles Using Intracellular and Extracellular Components of Fungi: An Alternative for Bacterial Inhibition.Antibiotics (Basel)2022https://conductscience.org/library/papers/35740206PubMed
225234047Synthesis, characterization and antifungal activity of chemically and fungal-produced silver nanoparticles against Trichophyton rubrum.J Appl Microbiol2014https://conductscience.org/library/papers/25234047PubMed
328324427Biosynthesis of silver nanoparticles from Schizophyllum radiatum HE 863742.1: their characterization and antimicrobial activity.3 Biotech2014https://conductscience.org/library/papers/28324427PubMed
424610039Antimicrobial activity and physical characterization of silver nanoparticles green synthesized using nitrate reductase from Fusarium oxysporum.Appl Biochem Biotechnol2014https://conductscience.org/library/papers/24610039PubMed
528053592Extracellular biosynthesis of silver nanoparticles using Rhizopus stolonifer.Saudi J Biol Sci2017https://conductscience.org/library/papers/28053592PubMed
621088776Extracellular biosynthesis and characterization of silver nanoparticles using Aspergillus flavus NJP08: a mechanism perspective.Nanoscale2011https://conductscience.org/library/papers/21088776PubMed
738255936Macrofungal Mediated Biosynthesis of Silver Nanoparticles and Evaluation of Its Antibacterial and Wound-Healing Efficacy.Int J Mol Sci2024https://conductscience.org/library/papers/38255936PubMed
825485188Biogenic silver nanoparticles associated with silver chloride nanoparticles (Ag@AgCl) produced by laccase from Trametes versicolor.Springerplus2014https://conductscience.org/library/papers/25485188PubMed
935736088Biological Synthesis of Low Cytotoxicity Silver Nanoparticles (AgNPs) by the Fungus Chaetomium thermophilum-Sustainable Nanotechnology.J Fungi (Basel)2022https://conductscience.org/library/papers/35736088PubMed
1016014167Mechanistic aspects of biosynthesis of silver nanoparticles by several Fusarium oxysporum strains.J Nanobiotechnology2005https://conductscience.org/library/papers/16014167PubMed
1133878753Poly(L-DOPA)-mediated bimetallic core-shell nanostructures of gold and silver and their employment in SERS, catalytic activity, and cell viability.Nanotechnology2021https://conductscience.org/library/papers/33878753PubMed
1240325316Eco-friendly biosynthesis of silver nanoparticles using marine-derived Fusarium exquisite: optimization, characterization, and evaluation of antimicrobial, antioxidant, and cytotoxic activities.World J Microbiol Biotechnol2025https://conductscience.org/library/papers/40325316PubMed
1341597696Saccharomyces cerevisiae Response to Magnetic Stress: Role of a Protein Corona in Stable Biosynthesis of Silver Nanoparticles.Microorganisms2026https://conductscience.org/library/papers/41597696PubMed
1440258887Biosynthesis of silver nanoparticles by Talaromyces funiculosus for therapeutic applications and safety evaluation.Sci Rep2025https://conductscience.org/library/papers/40258887PubMed
1528965140Fungi-assisted silver nanoparticle synthesis and their applications.Bioprocess Biosyst Eng2018https://conductscience.org/library/papers/28965140PubMed
1639590717Extracellular Biosynthesis, Characterization and Antimicrobial Activity of Silver Nanoparticles Synthesized by Filamentous Fungi.J Fungi (Basel)2024https://conductscience.org/library/papers/39590717PubMed
1741188306Green synthesis and characterization of silver nanoparticles from Gilaburu under varying temperature and pH, with antimicrobial activity and spectral inconsistencies.Sci Rep2025https://conductscience.org/library/papers/41188306PubMed
1831696113Synthesis of Silver Nanoparticles Mediated by Fungi: A Review.Front Bioeng Biotechnol2019https://conductscience.org/library/papers/31696113PubMed
1917037870Possible binding sites for biotin stabilized water soluble Ag nanoparticles: an experimental and theoretical study.J Nanosci Nanotechnol2006https://conductscience.org/library/papers/17037870PubMed
2037932769Mycosynthesis of silver nanoparticles from endophytic Aspergillus flavipes AUMC 15772: ovat-statistical optimization, characterization and biological activities.Microb Cell Fact2023https://conductscience.org/library/papers/37932769PubMed

See all 82 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn PapersSource
42776243Current challenges and future directions in the green synthesis of nanoparticles using fungi.Bioprocess Biosyst Eng2026https://conductscience.org/library/papers/42776243PubMed
42730168Biogenic nanoparticles: overview of challenges in production, characterization and use.Front Chem2026https://conductscience.org/library/papers/42730168PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42450296

GET https://conductscience.org/api/papers/v1/42450296/references?page=2